Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bersanelli

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 27, 2019
Network indirect comparison of 3 BRAF + MEK inhibitors for the treatment of advanced BRAF mutated melanomaF Consoli, M Bersanelli, G Perego, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: the GRANT score applied to the ASSURE trial populationS Buti, M Puligandla, M Bersanelli, et al.
Technology in Cancer Research & Treatment|February 17, 2012
Prognostic value of 18F-FDG standard uptake value by integrated PET/CT in the staging of malignant pleural mesotheliomaG Genestreti, A Moretti, S Piciucchi, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2020
Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patientsG Mazzaschi, R Minari, A Zecca, et al.
ESMO Open|July 19, 2023
An Italian multicenter retrospective real-life analysis of patients with brain metastases from renal cell carcinoma: the BMRCC studyV Internò, F Massari, R Rudà, et al.
Journal of Thrombosis and Haemostasis : JTH|October 16, 2015
Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patientsT van der Hulle, P L den Exter, B Planquette, et al.
Physical Review Letters|March 28, 2015
Joint analysis of BICEP2/keck array and Planck DataP A R Ade, N Aghanim, Z Ahmed, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 27, 2019
Network indirect comparison of 3 BRAF + MEK inhibitors for the treatment of advanced BRAF mutated melanomaF Consoli, M Bersanelli, G Perego, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: the GRANT score applied to the ASSURE trial populationS Buti, M Puligandla, M Bersanelli, et al.
Technology in Cancer Research & Treatment|February 17, 2012
Prognostic value of 18F-FDG standard uptake value by integrated PET/CT in the staging of malignant pleural mesotheliomaG Genestreti, A Moretti, S Piciucchi, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2020
Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patientsG Mazzaschi, R Minari, A Zecca, et al.
ESMO Open|July 19, 2023
An Italian multicenter retrospective real-life analysis of patients with brain metastases from renal cell carcinoma: the BMRCC studyV Internò, F Massari, R Rudà, et al.
Journal of Thrombosis and Haemostasis : JTH|October 16, 2015
Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patientsT van der Hulle, P L den Exter, B Planquette, et al.
Physical Review Letters|March 28, 2015
Joint analysis of BICEP2/keck array and Planck DataP A R Ade, N Aghanim, Z Ahmed, et al.
Pageof 1